Therapeutic Segments

Our portfolio is diverse and based upon - Market Research, Regulatory & IP taking into consideration Emerging, Expansion and Regulated markets.

  1. Oncology
  2. Biosimilars
  3. Women's Health
    1. Osteoporosis
    2. Anaemia
    3. Gynaecology
  4. Lifestyle Drugs
    1. Diabetics
    2. Mental Illness
    3. Cardio
    4. CNS
  5. Nutrition Health